Trevena
TRVN
#10607
Rank
โ‚น0.92 M
Marketcap
โ‚น1.07
Share price
0.00%
Change (1 day)
-99.19%
Change (1 year)

Earnings for Trevena (TRVN)

Earnings in 2024 (TTM): -โ‚น2.59 Billion

According to Trevena's latest financial reports the company's current earnings are โ‚น0.54 Million. In 2023 the company made an earning of -โ‚น3.26 Billion, an increase over its 2022 earnings that were of -โ‚น4.7 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevena from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น2.59 Billion-20.4%
2023 -โ‚น3.26 Billion-30.69%
2022 -โ‚น4.7 Billion1.38%
2021 -โ‚น4.64 Billion78.04%
2020 -โ‚น2.61 Billion21.3%
2019 -โ‚น2.15 Billion-13.91%
2018 -โ‚น2.5 Billion-59.75%
2017 -โ‚น6.19 Billion-31.77%
2016 -โ‚น9.07 Billion101.73%
2015 -โ‚น4.5 Billion1.14%
2014 -โ‚น4.45 Billion114.83%
2013 -โ‚น2.07 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚น738.26 B-26,645.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-โ‚น67.34 Billion 2,321.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-โ‚น5.63 Billion 102.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.067 T-74,449.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-โ‚น56.15 Billion 1,918.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-โ‚น0.93 Billion-66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-โ‚น7.11 Billion 155.63%๐Ÿ‡บ๐Ÿ‡ธ USA